CLINICAL_TRIALS
trial_result
· 2012-03-27
Clinical Trial Update: Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea [Phase 3]
Summary
Phase 3 trial evaluating octreotide LAR to prevent chemotherapy-induced diarrhea has completed; results were posted on 2012-03-27.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chemotherapy-induced Diarrhea | Phase 3 | Status: COMPLETED | Results posted: 2012-03-27